JPRN-UMIN000003781已完成未知
The effect of pranlukast on alveolar exhaled nitric oxide in patients with asthma under inhaled corticosteroid therapy; Open-labeled, cross-over trial. - Pranlukast and eNO in asthma under ICS therapy
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
The addition of oral pranlukast to ICS or ICS + LABA therapy may improve asthma control with reducing distal airway inflammation.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criterias are as follows. 1. Patients during asthmatic attack,or infectious disease to treat with priority. 2. Patients with history of hypersensitivity to pranlukast. 3. Patients with complications as pneumothorax or severe heart failure. 4. Judgement of attending physician.
研究者
相似试验
已完成
4 期
The additive effects of Pranlukast in stable asthmatic patients with the regular use of FP/LABA combination drug –(1) Open-label, randomized and comparative study–AsthmaJPRN-UMIN000001006JA Tohno Kousei Hospital50
已完成
4 期
The additive effects of Pranlukast in stable asthmatic patients with the regular use of FP/LABA combination drug (2) Open-label, randomized, and cross-over studyAsthmaJPRN-UMIN000001007JA Tohno Kousei Hospital50
已完成
3 期
Effects of Montelukast in Children With AsthmaAsthmaNCT00675285Catholic University of the Sacred Heart26
尚未招募
不适用
Efficacy of pranlukast for nasal symptoms and physical activity in asthma children with moderate/severe allergic rhinitisallergic rhinitisJPRN-UMIN000011408Mie National Hospital60
已完成
不适用
Effect of Pranlukast on allergic symptoms and nasal Nitric oxide levels in patients with Japanese cedar pollinosisJPRN-UMIN000004585The Jikei University School of Medicine18